Skip to main content

Articles

Page 1 of 28

  1. Emergency Departments (ED) staff, including nurses and physicians, are most directly involved in the care of people who use unregulated substances, and are ideally positioned to provide harm reduction interven...

    Authors: Sunny Jiao, Vicky Bungay, Emily Jenkins and Marilou Gagnon
    Citation: Harm Reduction Journal 2024 21:171
    Content type: Research Published on:

  2. Over the last decade, India has had an alarming rise in injection of opioids across several cities. Although scale-up of public sector services for people who inject drugs (PWID) in India has occurred over dec...

    Authors: Lakshmi Ganapathi, Aylur K. Srikrishnan, Allison M. McFall, Mihili P. Gunaratne, Muniratnam Suresh Kumar, Gregory M. Lucas, Shruti H. Mehta and Sunil S. Solomon
    Citation: Harm Reduction Journal 2024 21:170
    Content type: Perspective Published on:

  3. Fentanyl is increasingly pervasive in the unregulated drug supply and is a driver of drug overdose deaths in the United States. The aims of this study were to characterize and identify correlates of fentanyl p...

    Authors: Siena C. Napoleon, Carolyn J. Park, Jacqueline Goldman, Yu Li, Jane A. Buxton, Alexandria Macmadu, Katie B. Biello, Julia Noguchi and Brandon D.L. Marshall
    Citation: Harm Reduction Journal 2024 21:169
    Content type: Research Published on:

  6. Cannabis is the most common illicit substance used in pregnancy. As use continues to increase, understanding peoples’ behaviors surrounding cannabis use during pregnancy is needed to improve maternal and child...

    Authors: Erin E. Gould, Siddhi S. Ganesh and Rachel Carmen Ceasar
    Citation: Harm Reduction Journal 2024 21:166
    Content type: Research Published on:

  7. Opioid use disorder (OUD) poses a global health challenge, and despite medications for opioid use disorder (MOUD) and psychosocial interventions, relapse remains a significant concern. Comorbid psychiatric dis...

    Authors: Auxane Beslot, Marie Grall-Bronnec, Marianne Balem, Benoit Schreck, Edouard-Jules Laforgue, Caroline Victorri-Vigneau, Morgane Guillou-Landreat, Juliette Leboucher, Gaëlle Challet-Bouju and Clémence Cabelguen
    Citation: Harm Reduction Journal 2024 21:165
    Content type: Research Published on:

  9. In this article the authors offer their perspective on the changes in the Dutch harm reduction field. From the 1970s to the 1990s, the Netherlands emerged as a leader in harm reduction services, driven by gras...

    Authors: Machteld Busz, Katrin Schiffer, Ancella Voets and Alice Pomfret
    Citation: Harm Reduction Journal 2024 21:163
    Content type: Perspective Published on:

  10. Xylazine is an increasingly common adulterant in the North American unregulated drug supply that is associated with adverse health outcomes (e.g., skin infections, overdose). However, there are significant kno...

    Authors: William H. Eger, Marina Plesons, Tyler S. Bartholomew, Angela R. Bazzi, Maia H. Hauschild, Corbin C. McElrath, Cyrus Owens, David W. Forrest, Hansel E. Tookes and Erika L. Crable
    Citation: Harm Reduction Journal 2024 21:162
    Content type: Research Published on:

  11. Despite the widespread use of the phrase “harm reduction” and the proliferation of programs based on its principles during the current opioid epidemic, what it means in practice is not universally agreed upon....

    Authors: Jill Owczarzak, Emily Martin, Noelle Weicker, Imogen Evans, Miles Morris and Susan G. Sherman
    Citation: Harm Reduction Journal 2024 21:161
    Content type: Research Published on:

  12. Direct acting antivirals (DAAs) as a curative treatment of hepatitis C have been available for several years and have replaced interferon-containing therapies. However, treatment rates of people who inject dru...

    Authors: Patrik Roser, Mona Brunstein, Michael Specka, Jörg Timm, Stefan Kühnhold, Fabrizio Schifano, Udo Bonnet and Norbert Scherbaum
    Citation: Harm Reduction Journal 2024 21:160
    Content type: Research Published on:

  13. 2-Benzylbenzimidazole ‘nitazene’ opioids pose a growing threat to public health. Nitazene analogues are increasingly found mixed with or (mis)sold as heroin and in falsified (non-)opioid medications, posing a ...

    Authors: Liam M. De Vrieze, Christophe P. Stove and Marthe M. Vandeputte
    Citation: Harm Reduction Journal 2024 21:159
    Content type: Research Published on:

  14. This commentary outlines the development of an Inclusion Collaborative in a large health district in Sydney, New South Wales Australia. The Collaborative grew out of ongoing efforts to reduce stigma associated...

    Authors: Louise Maher, Bronwyn Leece, Felicity Sheaves, Andrew Wilson, James Brown, Lauren O’Connell, Megan Carnegie-Brown, Linda Stanbury, Una Turalic, Deanna Mooney, Larissa Hoyling, Elena Cama and Carla Treloar
    Citation: Harm Reduction Journal 2024 21:158
    Content type: Comment Published on:

  15. Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants. SSPs can use these...

    Authors: Elise Healy, Arianna Rubin Means, Kelly Knudtson, Noah Frank, Alexa Juarez, Stephanie Prohaska, Courtney McKnight, Don Des Jarlais, Alice Asher and Sara N. Glick
    Citation: Harm Reduction Journal 2024 21:157
    Content type: Research Published on:

  16. Fentanyl and fentanyl analogues have disrupted the illicit drug supply through contamination of other substances (i.e., methamphetamine and cocaine) and replacement of heroin in illicit markets. Increasingly, ...

    Authors: Maria Bolshakova, Kelsey A. Simpson, Siddhi S. Ganesh, Jesse L. Goldshear, Cheyenne J. Page and Ricky N. Bluthenthal
    Citation: Harm Reduction Journal 2024 21:156
    Content type: Brief Report Published on:

  17. Overdose prevention sites (OPS) are a harm reduction strategy that offer people who use drugs a variety of resources including but not limited to sterile supplies, linkage to healthcare resources, and interven...

    Authors: Emily Paz, Vahid Mashhouri, Mark E. Payton, Brian D. Schwartz and Rachel M.A. Linger
    Citation: Harm Reduction Journal 2024 21:155
    Content type: Research Published on:

  18. Illicitly manufactured fentanyl and its analogs are the primary drivers of opioid overdose deaths in the United States (U.S.). People who use drugs may be exposed to fentanyl or its analogs intentionally or un...

    Authors: Suzan M. Walters, Robin Baker, David Frank, Monica Fadanelli, Abby E. Rudolph, William Zule, Rob J. Fredericksen, Rebecca Bolinski, Adams L. Sibley, Vivian F. Go, Lawrence J. Ouellet, Mai T. Pho, David W. Seal, Judith Feinberg, Gordon Smith, April M. Young…
    Citation: Harm Reduction Journal 2024 21:154
    Content type: Research Published on:

  19. Since the beginning of the COVID-19 pandemic, COVID-19 risk mitigation measures have expanded to include increased rules and surveillance in supportive housing. Yet, in the context of the dual public health em...

    Authors: Jenn McDermid, Jennie Pearson, Melissa Braschel, Sarah Moreheart, Rory Marck, Kate Shannon, Andrea Krüsi and Shira M. Goldenberg
    Citation: Harm Reduction Journal 2024 21:153
    Content type: Research Published on:

  20. Fentanyl test strips (FTS) are lateral flow immunoassays that were originally designed and validated for detecting low concentrations of fentanyl in urine. Some FTS are now being marketed for the harm reductio...

    Authors: Hirudini Fernando, Anita Amate, Kathleen L. Hayes, Heather D. Whitehead, Charlie Desnoyers, Emmanuel Uzobuife, Madison S. Denchfield, Braden Whitelatch and Marya Lieberman
    Citation: Harm Reduction Journal 2024 21:152
    Content type: Perspective Published on:

  23. Studies have shown that contamination of surfaces by illicit drugs frequently occurs in forensic laboratories when manipulating seized samples as well as in pharmacies and hospitals when preparing medicinal dr...

    Authors: Flore Cuffaro, Georges Dahm, Claude Marson, Patrick Berlemont, Michel Yegles, Claudia Allar, Lionel Fauchet, Matteo Creta and Serge Schneider
    Citation: Harm Reduction Journal 2024 21:149
    Content type: Research Published on:

  24. Xylazine is increasingly prevalent in the unregulated opioid supply in the United States. Exposure to this adulterant can lead to significant harm, including prolonged sedation and necrotic wounds. In the abse...

    Authors: Katherine Hill, Rebecca Minahan-Rowley, Emma T. Biegacki, Robert Heimer and Kimberly L. Sue
    Citation: Harm Reduction Journal 2024 21:148
    Content type: Research Published on:

  25. Prisons often serve as high-risk environments for drug use, and incarcerated people are at a high risk for substance use-related mental and physical harms. This study aimed to determine the prevalence of non-i...

    Authors: Mahkameh Rafiee, Mohammad Karamouzian, Mohammad Sharifi, Ali Mirzazadeh, Mehrdad Khezri, Ali Akbar Haghdoost, Soheil Mehmandoost and Hamid Sharifi
    Citation: Harm Reduction Journal 2024 21:147
    Content type: Research Published on:

  27. Scientific evidence clearly demonstrates that inhaling the smoke from the combustion of cigarettes is responsible for most of the harm caused by smoking, and not the nicotine. However, a majority of U.S. adult...

    Authors: Thaddaeus Hannel, Lai Wei, Raheema S. Muhammad-Kah, Edward G. Largo and Mohamadi Sarkar
    Citation: Harm Reduction Journal 2024 21:145
    Content type: Research Published on:

  30. Electronic nicotine delivery systems (ENDS) offer a promising approach to tobacco harm reduction, but many people use both ENDS and combustible cigarettes (“dual use”), which undermines potential risk reductio...

    Authors: Jed E. Rose, Frederique M. Behm, Gal Cohen, Perry N. Willette, Tanaia L. Botts and David R. Botts
    Citation: Harm Reduction Journal 2024 21:142
    Content type: Research Published on:

  31. Supervised consumption sites (SCS) and overdose prevention sites (OPS) have been implemented across Canada to mitigate harms associated with illicit substance use. Despite their successes, they still contend w...

    Authors: Boogyung Seo, William Rioux, Adrian Teare, Nathan Rider, Stephanie Jones, Pamela Taplay and S. Monty Ghosh
    Citation: Harm Reduction Journal 2024 21:141
    Content type: Research Published on:

  32. The hepatitis C virus (HCV) causes chronic and curable disease with a substantial burden of morbidity and mortality across the globe. In the United States (US) and other developed countries, incidence of HCV i...

    Authors: Erin Bredenberg, Catherine Callister, Ashley Dafoe, Brooke Dorsey Holliman, Sarah E. Rowan and Susan L. Calcaterra
    Citation: Harm Reduction Journal 2024 21:140
    Content type: Research Published on:

  33. The COVID-19 pandemic has posed significant challenges to nations worldwide, affecting various sectors of society. Women’s HIV harm reduction centers, which provide critical services, have also been affected b...

    Authors: Azam Rahmani, Maryam Janatolmakan, Elham Rezaei, Leila Allahqoli, Arezoo Fallahi, Elham Ebrahimi, Mahnaz Motamedi, Fatemeh Yousefi and Serap Ejdar Apay
    Citation: Harm Reduction Journal 2024 21:139
    Content type: Research Published on:

  34. Opioid-related overdose is the leading cause of death for people recently released from incarceration, however treatment with medications for opioid use disorder (MOUD) during incarceration can reduce the mort...

    Authors: Pryce S. Michener, Elyse Bianchet, Shannon Fox, Elizabeth A. Evans and Peter D. Friedmann
    Citation: Harm Reduction Journal 2024 21:138
    Content type: Research Published on:

  35. In Pittsburgh, PA, legal changes in recent decades have set the stage for an expanded role for community pharmacists to provide harm reduction services, including distributing naloxone and non-prescription syr...

    Authors: Caitlin O’Brien, Stephanie Klipp, Raagini Jawa and J. Deanna Wilson
    Citation: Harm Reduction Journal 2024 21:137
    Content type: Research Published on:

  36. If US adults who smoke cigarettes are switching to e-cigarettes, the effect may be observable at the population level: smoking prevalence should decline as e-cigarette prevalence increases, especially in sub-p...

    Authors: Floe Foxon, Arielle Selya, Joe Gitchell and Saul Shiffman
    Citation: Harm Reduction Journal 2024 21:136
    Content type: Research Published on:

  37. Cannabidiol (CBD) is a widely available cannabis product with many claims as to potential health benefits including alleviating symptoms related to opioid use disorder (OUD). However, little is known as to how...

    Authors: Christopher Kudrich, Rebecca Chen, Yuan Meng, Keren Bachi and Yasmin L. Hurd
    Citation: Harm Reduction Journal 2024 21:135
    Content type: Research Published on:

  38. Drug overdose is a leading cause of death and opioid-related deaths increased by more than 300% from 2010 to 2020 in New York State. Experts holding a range of senior leadership positions from across New York ...

    Authors: Daniel J. Kruger, Hilary M. Kirk, Kenneth E. Leonard, Joshua J. Lynch, Nancy Nielsen, R. Lorraine Collins, Joseph W. Ditre, Debbian Fletcher-Blake, Susan A. Green, Aaron Hogue, Julia K. Hunter, John M. Marraffa and Brian M. Clemency
    Citation: Harm Reduction Journal 2024 21:134
    Content type: Research Published on:

  39. The COVID-19 pandemic posed significant challenges for managers overseeing women's harm reduction centers. This study seeks to capture managers' perspectives on the service providing in women's harm reduction ...

    Authors: Azam Rahmani, Maryam Janatolmakan, Elham Rezaei and Malihe Tabarrai
    Citation: Harm Reduction Journal 2024 21:133
    Content type: Research Published on:

    The Correction to this article has been published in Harm Reduction Journal 2024 21:144

  41. Harm reduction is a crucial approach in addressing the multifaceted challenges of injectable drug use. This paper presents an analysis and mapping of the existing literature on harm reduction research in the c...

    Authors: Waleed M. Sweileh
    Citation: Harm Reduction Journal 2024 21:131
    Content type: Research Published on:

  42. New types of nicotine and tobacco products like electronic cigarettes (ECs), heated tobacco products or nicotine pouches have been discussed as less harmful alternatives to combustible cigarettes and other tox...

    Authors: Nikola Pluym, Therese Burkhardt, Gerhard Scherer and Max Scherer
    Citation: Harm Reduction Journal 2024 21:130
    Content type: Review Published on:

  44. Deaths due to drug overdose are an international issue, causing an estimated 128,000 global deaths in 2019. Scotland has the highest rate of drug-related deaths in Europe, with those in the most deprived areas...

    Authors: Graeme Strachan, Hadi Daneshvar, Hannah Carver, Jessica Greenhalgh and Catriona Matheson
    Citation: Harm Reduction Journal 2024 21:128
    Content type: Research Published on:

  45. Since late 2019, fortification of ‘regular’ cannabis plant material with synthetic cannabinoid receptor agonists (SCRAs) has become a notable phenomenon on the drug market. As many SCRAs pose a higher health r...

    Authors: Axelle Timmerman, Margot Balcaen, Vera Coopman, Maarten Degreef, Eline Pottie and Christophe P. Stove
    Citation: Harm Reduction Journal 2024 21:127
    Content type: Research Published on:

  46. Needle and syringe programs (NSP) are effective harm-reduction strategies against HIV and hepatitis C. Although skin, soft tissue, and vascular infections (SSTVI) are the most common morbidities in people who ...

    Authors: Jihoon Lim, W. Alton Russell, Mariam El-Sheikh, David L. Buckeridge and Dimitra Panagiotoglou
    Citation: Harm Reduction Journal 2024 21:126
    Content type: Research Published on:

    The Correction to this article has been published in Harm Reduction Journal 2024 21:164

  47. Patients with opioid use disorder (OUD) experience various forms of stigma at the individual, public, and structural levels that can affect how they access and engage with healthcare, particularly with medicat...

    Authors: Jessica V. Couch, Mackenzie Whitcomb, Bradley M. Buchheit, David A. Dorr, Darren J. Malinoski, P. Todd Korthuis, Sarah S. Ono and Ximena A. Levander
    Citation: Harm Reduction Journal 2024 21:125
    Content type: Research Published on:

  48. Good Samaritan Laws are a harm reduction policy intended to facilitate a reduction in fatal opioid overdoses by enabling bystanders, first responders, and health care providers to assist individuals experienci...

    Authors: Rachel L. Thompson, Nasim S. Sabounchi, Syed Shayan Ali, Robert Heimer, Gail D’Onofrio and Rebekah Heckmann
    Citation: Harm Reduction Journal 2024 21:124
    Content type: Research Published on:

  49. People who inject drugs (PWID) are at risk of HIV acquisition. The number of PWID in South African cities is increasing, and in spite of an advanced HIV prevention and treatment programme, there are PWID who e...

    Authors: Cecilia Milford, Tammany Cavanagh, Shannon Bosman, Michael Wilson, Jennifer Smit and Brian Zanoni
    Citation: Harm Reduction Journal 2024 21:123
    Content type: Research Published on:

  50. The present commentary highlights the pressing need for systematic research to assess the implementation and effectiveness of medications for opioid use disorder, used in conjunction with peer recovery support...

    Authors: Kimberly Horn, Stephanie M. Mathis, Lara Nagle, Angela Hagaman, Mary Beth Dunkenberger and Robert Pack
    Citation: Harm Reduction Journal 2024 21:122
    Content type: Comment Published on:
Submit manuscript
  • ISSN: 1477-7517 (electronic)

Harm Reduction Journal

ISSN: 1477-7517